In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions

Peritoneal Dialysis International

Volumn 17, Issue 1, 1997, Pages 42-47

  Topley, Nicholas ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bicarbonate; Biocompatibility; Buffer; Dialysis solutions; Peritoneal cells; pH

Indexed keywords

BICARBONATE; GLUCOSE; LACTIC ACID; PERITONEAL DIALYSIS FLUID;

ARTICLE; BIOCOMPATIBILITY; CELL FUNCTION; CELL PH; CELL SURVIVAL; HUMAN; LEUKOCYTE FUNCTION; MEDICAL LITERATURE; MESOTHELIUM CELL; OSMOLALITY; PERITONEUM CELL; PH; PRIORITY JOURNAL;

BICARBONATES; BIOCOMPATIBLE MATERIALS; BUFFERS; DIALYSIS SOLUTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; PERITONEAL DIALYSIS; PERITONEUM;

EID: 0030691943     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
2. Holmes CJ. Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993; 13:88-94.
3. Holmes CJ. Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int. 1994; 46:S58-70.
4. Topley N, Williams JD. The role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 1994; 46:S71-78.
5. Topley N, Jörres A, Mackenzie R, Coles GA, Williams JD. Interactions of macrophages and mesothelial cells in peritoneal host defense. Nieren-und Hochdruckkrankheiten 1994; 23:S88-91.
6. Jörres A, Gahl GM, Frei U. Peritoneal dialysis fluid biocompatibility: does it really matter? Kidney Int 1994; 46:S79-86.
7. Veech RL. The untoward effects of the anions of dialysis fluids. Kidney Int 1988; 34:587-97.
8. Feriani M, Biasioli S, Borin D, et al. Bicarbonate solutions for peritoneal dialysis: a reality. Int J Artif Organs 1985; 8:57-8.
9. Yatzidis H. A new stable bicarbonate dialysis solution for peritoneal dialysis: preliminary report. Perit Dial Int 1991; 11:224-7.
10. Jörres A, Topley N, Witowski J, Liberek T, Gahl GM. Impact of peritoneal dialysis solutions on peritoneal immune defense. Perit Dial Int 1993; 13:S291-4.
11. Jörres A, Topley N, Gahl GM. Biocompatibility of peritoneal dialysis fluids [editorial]. Int J Artif Organs 1992; 15:79-83.
12. Topley N, Coles GA, Williams JD. Biocompatibility studies on peritoneal cells. Perit Dial Int 1994; 14:S21-8.
13. Jörres A, Topley N, Williams JD, Gahl GM. Einfluss der Dialysatzusammensetzung auf die Zytikinprodution von Leukozyten und peritonealen Mesothelzellen. Nieren-und Hochdruckkrankheiten 1994; 23:S100-4.
14. Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40:77-9.
15. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PTT, Boberg UC. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993; 39:343-8.
16. Liberek T, Topley N, Jörres A, et al. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65:260-5.
17. Douvdevani A, Rapoport J, Konforty A, et al. Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol 1995; 6:207-13.
18. Witowski J, Topley N, Jörres A, et al. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1995; 47:282-93.
19. Liberek T, Topley N, Jörres A, et al. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Nephrol 1993; 3:1508-15.
20. Jörres A, Gahl GM, Topley N, et al. In vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose polymer based solutions. Nephrol Dial Transplant 1994; 9:785-90.
21. Honda K, Nitta K, Horita H, Yumura W, Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72:171-6.
22. Manahan FJ, Ing BL, Chan JC, et al. Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils. Artif Organs 1989; 13:495-7.
23. Kristensen SR, Pedersen FB. Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts. Nephrol Dial Transplant 1993; 8:163-7.
24. Dobos GJ, Böhler J, Kuhlmann J, et al. Bicarbonate-based dialysis solutions preserves granulocyte functions. Perit Dial Int 1994; 14:366-70.
25. Zhou XJ, Yu AW, Zhou FQ, et al. Effects of an acidic, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart on neutrophilic intracellular pH. Int J Artif Organs 1993; 16:816-9.
26. Zhou XJ, Yu AW, Zhou FQ, et al. Neutrophil intracellular pH after exposure of neutrophils to a euhydric, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart. Int J Artif Organs 1995; 18:69-72.
27. Ing TS, Huie DA, Johnson V, et al. Effects of lactate-based and bicarbonate-based peritoneal dialysis solutions on neutrophilic oxygen consumption. Artif Organs 1995; 19:440-2.
28. Yu AW, Olabi Z, Gupta DK, et al. Effect of euhydric peritoneal dialysis solutions containing a mixture of bicarbonate and lactate or lactate alone on neutrophilic superoxide production. ASAIO Journal 1994; 40:M900-1.
29. Fischer H-P, Schenk U, Kiefer T, et al. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function. Am J Kid Dis 1995; 26:924-33.
30. Topley N, Kaur D, Petersen MM, et al. Biocompatibility of bicarbonate-buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996; 49:1447-56.
31. Topley N, Kaur D, Petersen MM, et al. In vitro effects of bicarbonate and bicarbonate/lactate-buffered peritoneal dialysis solutions on mesothelial cell and neutrophil function. J Am Soc Nephrol 1996; 7:218-24.
32. Yatzidis H. Enhanced ultrafiltration in rabbits with bicarbonate glycylglycine peritoneal dialysis solution. Perit Dial Int 1993; 13:302-6.
33. Schambye HT, Flesner P, Pedersen RB, et al. Bicarbonate- versus lactate-based CAPD fluids: a biocompatibility study in rabbits. Peru Dial Int 1992; 12:281-6.
34. Feriani M, Dissegna D, La Greca G, Passlick-Deetjen J, Short-term clinical study with bicarbonate-containing peritoneal dialysis solution. Perit Dial Int 1993; 13:296-301.
35. Feriani M, Passlick-Deetjen J, La Greca G. Factors affecting bicarbonate transfer with bicarbonate-containing CAPD solution. Perit Dial Int 1995; 15.
36. Yamamoto T, Sakakura T, Yamakawa M, et al. Clinical effects of long-term use of neutralised dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992; 60:324-9.
37. Ritter JM, Doktor HS, Benjamin N. Paradoxical effect of bicarbonate on cytoplasmic pH. Lancet 1990; 335:1243-6.
38. 3. Am J Physiol 1988; 255:C844-56.
39. - exchangers. Am J Physiol 1988; 255:C857-69.
40. Topley N, Mackenzie R, Petersen MM, et al. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991; 6:574-81.
41. de Fijter CWH, Verbrugh HA, Oe LP, et al. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 1992; 42:947-50.
42. de Fijter CWH, Verbrugh HA, Oe LP, et al. Biocompatibility of a glucose polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 1993; 4:411-8.
43. de Fijter CWH, Verbrugh HA, Peters EDJ, et al. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 1993; 39:75-80.
44. de Fijter CWH, Verbrugh HA, Oe PL, et al. Antibacterial peritoneal defense in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis? Nephrol Dial Transplant 1994; 9:156-62.
45. Gotloib L, Waisbrut V, Shostak A, Kushnier R. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions. Nephron 1995; 70:466-77.